Clinical Trial Update: Effect of Topical Melatonin Application on Dental Implant Osseointegration and Marginal Bone Level [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of topical melatonin on dental implant osseointegration and marginal bone level in alveolar bone loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Bone Loss
• Dental Implant Osseointegration

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: University of Baghdad | Conditions: Alveolar Bone Loss | Phase 3 | Status: UNKNOWN